Imexpharm (STC:IMP) Other Operating Expense : ₫56,735 Mil (TTM As of Mar. 2025)

View and export this data going back to 2006. Start your Free Trial

What is Imexpharm Other Operating Expense?

Imexpharm's Other Operating Expense for the three months ended in Mar. 2025 was ₫56,735 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₫56,735 Mil.

Imexpharm's quarterly Other Operating Expense declined from Sep. 2024 (₫0 Mil) to Dec. 2024 (₫0 Mil) but then increased from Dec. 2024 (₫0 Mil) to Mar. 2025 (₫56,735 Mil).

Imexpharm's annual Other Operating Expense increased from Dec. 2022 (₫187,937 Mil) to Dec. 2023 (₫193,990 Mil) and increased from Dec. 2023 (₫193,990 Mil) to Dec. 2024 (₫211,120 Mil).

Imexpharm Other Operating Expense Historical Data

The historical data trend for Imexpharm's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imexpharm Other Operating Expense Chart

Imexpharm Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

138,397.30

127,032.25

187,936.58

193,990.25

211,119.86

Imexpharm Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															45,976.17	-	-	-	56,735.12

Imexpharm Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫56,735 Mil.

Imexpharm Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Imexpharm's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Imexpharm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Imexpharm Corp (STC:IMP) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 Road 30/04 Street Ward 1, Cao Lanh City, Dongthap, VNM

Website

http://www.imexpharm.com

Imexpharm Corp is engaged in the manufacture, import, export, and trade of pharmaceuticals and medicinal chemical products. Its products include oral and injective antibiotic, digestion, central nervous system, cardiovascular, diabetes, musculoskeletal system, respiratory system, analgesic-anti-inflammatory, anti-allergy, ophthalmology, external drugs, and anti-parasitic, as well as vitamins and minerals.

Imexpharm Headlines

No Headlines